We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 90

Snoops and gossips beware: Ontario Government to introduce stiffer measures to protect patient privacy
  • Stikeman Elliott LLP
  • Canada
  • June 26 2015

Recently, the Government of Ontario announced its intent to strengthen the rules protecting patient privacy. If passed, these amendments to the


Government seeks feedback on new drug safety initiatives
  • Stikeman Elliott LLP
  • Canada
  • May 6 2015

As previously reported, the Food and Drugs Act (the Act) has been substantively amended by Bill C-17, also known as Vanessa's Law; the Bill received


Bill C-17 (Vanessa’s Law) receives third reading
  • Stikeman Elliott LLP
  • Canada
  • October 24 2014

Bill C-17, An Act to Amend the Foods and Drugs Act (Vanessa's Law) has proceeded through the committee process without amendment and was read for a


CSA report on medical marijuana issuer finds disappointing disclosure deficiencies
  • Stikeman Elliott LLP
  • Canada
  • February 23 2015

The Canadian Securities Administrators today released the results of CSA staff's review of continuous disclosure by reporting issuers announcing


Health Canada finalizes Risk Assessment Framework for the Consumer Product Safety Program
  • Stikeman Elliott LLP
  • Canada
  • March 24 2015

As previously reported at the consultation stage, Health Canada has completed its process of developing a Risk Assessment Framework (the Framework


Competition Bureau sets out preliminary views on patent agreement settlement enforcement
  • Stikeman Elliott LLP
  • Canada
  • October 27 2014

On September 23, 2014, John Pecman, the Commissioner of Competition, delivered the keynote address at the George Mason University Pharma Conference


Health Canada publishes guidance for industry on the reporting of incidents involving consumer products
  • Stikeman Elliott LLP
  • Canada
  • July 13 2015

On July 8, 2015, Health Canada released important guidance designed to help consumer product companies, including retailers, understand their


Supreme Court of Canada affirms constitutionality of provincial breathalyzer laws
  • Stikeman Elliott LLP
  • Canada
  • October 22 2015

The Supreme Court released its decision on October 16, 2015 in the case of Goodwin v. British Columbia (Superintendent of Motor Vehicles) dealing


Senate Committee releases final report on Prescription Pharmaceuticals in Canada
  • Stikeman Elliott LLP
  • Canada
  • March 30 2015

On March 10, 2015, the Standing Senate Committee on Social Affairs, Science and Technology (the Committee) released a final report entitled


Federal Court opines on precedential value of prior PM(NOC) proceedings and scope of experimental use exception to public disclosure
  • Stikeman Elliott LLP
  • Canada
  • November 24 2016

The Federal Court’s decision inthe consolidated proceedings of Bayer Inc. v Cobalt Pharmaceuticals Company offers useful guidance as to the